{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:a2572fa4-f295-4e72-82fe-483a124bcdf0","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-22T02:06:32.740903+00:00","published_at":"2026-10-21T04:47:21.26074+00:00","section":"committees","data":{"state":"PUBLISHED","committees":[{"committee_id":"alpha:committee:inmed-pharmaceuticals-inc:audit","name":"Audit","type":"audit","body":"board","chair":null,"members":[{"person":{"alpha_id":"alpha:person:andrew-hull","name":"Andrew Hull","canonical_url":"https://registry.alpha.ac/people/andrew-hull"},"committee_id":"alpha:committee:inmed-pharmaceuticals-inc:audit","committee_name":"Audit","role":"member","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_record:12","evidence_ids":["alpha:projection-evidence:ebf7b46941955283b019653e911fdb1bbfbc34681452ef5a323a9adbd2f08e80"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:nicole-lemerond","name":"Nicole Lemerond","canonical_url":"https://registry.alpha.ac/people/nicole-lemerond"},"committee_id":"alpha:committee:inmed-pharmaceuticals-inc:audit","committee_name":"Audit","role":"member","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_record:12","evidence_ids":["alpha:projection-evidence:ebf7b46941955283b019653e911fdb1bbfbc34681452ef5a323a9adbd2f08e80"],"assertion_class":"source_fact","verification_state":"source_reported"}],"financial_experts":[],"independence_requirements":null,"charter_url":null,"charter_version":null,"mandate":null,"responsibilities":[],"oversight":{"ai":null,"cyber":null,"risks":[]},"meeting_cadence":null,"valid_from":null,"valid_to":null,"status":"current","claim_ids":["alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_record:12","alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_appointment:13","alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_appointment:14"],"evidence_ids":["alpha:projection-evidence:ebf7b46941955283b019653e911fdb1bbfbc34681452ef5a323a9adbd2f08e80"]},{"committee_id":"alpha:committee:inmed-pharmaceuticals-inc:audit-compensation-chair-nominating-and-governance","name":"Audit; Compensation · Chair; Nominating and Governance","type":"audit","body":"board","chair":null,"members":[{"person":{"alpha_id":"alpha:person:nicole-lemerond","name":"Nicole Lemerond","canonical_url":"https://registry.alpha.ac/people/nicole-lemerond"},"committee_id":"alpha:committee:inmed-pharmaceuticals-inc:audit-compensation-chair-nominating-and-governance","committee_name":"Audit; Compensation · Chair; Nominating and Governance","role":"member","valid_from":"2022-01-01","valid_to":null,"status":"current","claim_id":"alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:d55657e2e1a85a098818eefcb09ca1c0203aefe37c594136198ef89ce00d144e"],"assertion_class":"source_fact","verification_state":"source_reported"}],"financial_experts":[],"independence_requirements":null,"charter_url":null,"charter_version":null,"mandate":null,"responsibilities":[],"oversight":{"ai":null,"cyber":null,"risks":[]},"meeting_cadence":null,"valid_from":"2022-01-01","valid_to":null,"status":"current","claim_ids":["alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:d55657e2e1a85a098818eefcb09ca1c0203aefe37c594136198ef89ce00d144e"]},{"committee_id":"alpha:committee:inmed-pharmaceuticals-inc:audit-compensation-nominating-and-governance-chair","name":"Audit; Compensation; Nominating and Governance · Chair","type":"audit","body":"board","chair":null,"members":[{"person":{"alpha_id":"alpha:person:andrew-hull","name":"Andrew Hull","canonical_url":"https://registry.alpha.ac/people/andrew-hull"},"committee_id":"alpha:committee:inmed-pharmaceuticals-inc:audit-compensation-nominating-and-governance-chair","committee_name":"Audit; Compensation; Nominating and Governance · Chair","role":"member","valid_from":"2016-01-01","valid_to":null,"status":"current","claim_id":"alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:5","evidence_ids":["alpha:projection-evidence:document:d55657e2e1a85a098818eefcb09ca1c0203aefe37c594136198ef89ce00d144e"],"assertion_class":"source_fact","verification_state":"source_reported"}],"financial_experts":[],"independence_requirements":null,"charter_url":null,"charter_version":null,"mandate":null,"responsibilities":[],"oversight":{"ai":null,"cyber":null,"risks":[]},"meeting_cadence":null,"valid_from":"2016-01-01","valid_to":null,"status":"current","claim_ids":["alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:d55657e2e1a85a098818eefcb09ca1c0203aefe37c594136198ef89ce00d144e"]},{"committee_id":"alpha:committee:inmed-pharmaceuticals-inc:compensation","name":"Compensation","type":"compensation","body":"board","chair":{"alpha_id":"alpha:person:nicole-lemerond","name":"Nicole Lemerond","canonical_url":"https://registry.alpha.ac/people/nicole-lemerond"},"members":[{"person":{"alpha_id":"alpha:person:nicole-lemerond","name":"Nicole Lemerond","canonical_url":"https://registry.alpha.ac/people/nicole-lemerond"},"committee_id":"alpha:committee:inmed-pharmaceuticals-inc:compensation","committee_name":"Compensation","role":"chair","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_record:15","evidence_ids":["alpha:projection-evidence:ebf7b46941955283b019653e911fdb1bbfbc34681452ef5a323a9adbd2f08e80"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:andrew-hull","name":"Andrew Hull","canonical_url":"https://registry.alpha.ac/people/andrew-hull"},"committee_id":"alpha:committee:inmed-pharmaceuticals-inc:compensation","committee_name":"Compensation","role":"member","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_record:15","evidence_ids":["alpha:projection-evidence:ebf7b46941955283b019653e911fdb1bbfbc34681452ef5a323a9adbd2f08e80"],"assertion_class":"source_fact","verification_state":"source_reported"}],"financial_experts":[],"independence_requirements":null,"charter_url":null,"charter_version":null,"mandate":null,"responsibilities":[],"oversight":{"ai":null,"cyber":null,"risks":[]},"meeting_cadence":null,"valid_from":null,"valid_to":null,"status":"current","claim_ids":["alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_record:15","alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_appointment:16","alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_appointment:17"],"evidence_ids":["alpha:projection-evidence:ebf7b46941955283b019653e911fdb1bbfbc34681452ef5a323a9adbd2f08e80"]},{"committee_id":"alpha:committee:inmed-pharmaceuticals-inc:nominating-and-governance","name":"Nominating and Governance","type":"nominating_governance","body":"board","chair":{"alpha_id":"alpha:person:andrew-hull","name":"Andrew Hull","canonical_url":"https://registry.alpha.ac/people/andrew-hull"},"members":[{"person":{"alpha_id":"alpha:person:andrew-hull","name":"Andrew Hull","canonical_url":"https://registry.alpha.ac/people/andrew-hull"},"committee_id":"alpha:committee:inmed-pharmaceuticals-inc:nominating-and-governance","committee_name":"Nominating and Governance","role":"chair","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_record:18","evidence_ids":["alpha:projection-evidence:ebf7b46941955283b019653e911fdb1bbfbc34681452ef5a323a9adbd2f08e80"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:nicole-lemerond","name":"Nicole Lemerond","canonical_url":"https://registry.alpha.ac/people/nicole-lemerond"},"committee_id":"alpha:committee:inmed-pharmaceuticals-inc:nominating-and-governance","committee_name":"Nominating and Governance","role":"member","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_record:18","evidence_ids":["alpha:projection-evidence:ebf7b46941955283b019653e911fdb1bbfbc34681452ef5a323a9adbd2f08e80"],"assertion_class":"source_fact","verification_state":"source_reported"}],"financial_experts":[],"independence_requirements":null,"charter_url":null,"charter_version":null,"mandate":null,"responsibilities":[],"oversight":{"ai":null,"cyber":null,"risks":[]},"meeting_cadence":null,"valid_from":null,"valid_to":null,"status":"current","claim_ids":["alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_record:18","alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_appointment:19","alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_appointment:20"],"evidence_ids":["alpha:projection-evidence:ebf7b46941955283b019653e911fdb1bbfbc34681452ef5a323a9adbd2f08e80"]}]},"claims":[{"id":"alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:5","subject_id":"alpha:company:a2572fa4-f295-4e72-82fe-483a124bcdf0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:andrew-hull","object_label":"Andrew Hull","object_source_name_forms":[],"value":"Andrew Hull: Director, Audit; Compensation; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:andrew-hull","name":"Andrew Hull"},"title":"Director","role_category":"director","committee":"Audit; Compensation; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2016-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2016-01-01","valid_to":null,"recorded_at":"2026-10-21T04:47:21.26074+00:00","sources":[{"id":"alpha:projection-evidence:document:d55657e2e1a85a098818eefcb09ca1c0203aefe37c594136198ef89ce00d144e","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"InMed Pharmaceuticals Inc. DEF 14A 2025-11-03","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390025104914/ea0262858-def14a_inmed.htm","source_date":"2025-11-03","retrieved_at":"2026-04-28T22:18:02.792+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-11-03","effective_from":"2016-01-01","effective_until":null,"observed_at":"2026-10-21T04:47:21.26074+00:00","reviewed_at":"2026-10-21T04:47:21.26074+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:9","subject_id":"alpha:company:a2572fa4-f295-4e72-82fe-483a124bcdf0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:nicole-lemerond","object_label":"Nicole Lemerond","object_source_name_forms":[],"value":"Nicole Lemerond: Director, Audit; Compensation · Chair; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:nicole-lemerond","name":"Nicole Lemerond"},"title":"Director","role_category":"director","committee":"Audit; Compensation · Chair; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-21T04:47:21.26074+00:00","sources":[{"id":"alpha:projection-evidence:document:d55657e2e1a85a098818eefcb09ca1c0203aefe37c594136198ef89ce00d144e","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"InMed Pharmaceuticals Inc. DEF 14A 2025-11-03","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390025104914/ea0262858-def14a_inmed.htm","source_date":"2025-11-03","retrieved_at":"2026-04-28T22:18:02.792+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-11-03","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-21T04:47:21.26074+00:00","reviewed_at":"2026-10-21T04:47:21.26074+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_record:12","subject_id":"alpha:company:a2572fa4-f295-4e72-82fe-483a124bcdf0","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair not stated; Members Andrew Hull; Nicole Lemerond","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":null,"members":[{"display_name":"Andrew Hull","person_slug":"andrew-hull","is_chair":false},{"display_name":"Nicole Lemerond","person_slug":"nicole-lemerond","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-21T04:47:21.26074+00:00","sources":[{"id":"alpha:projection-evidence:ebf7b46941955283b019653e911fdb1bbfbc34681452ef5a323a9adbd2f08e80","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390025104914/ea0262858-def14a_inmed.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-21T04:47:21.26074+00:00","reviewed_at":"2026-10-21T04:47:21.26074+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_appointment:13","subject_id":"alpha:company:a2572fa4-f295-4e72-82fe-483a124bcdf0","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:andrew-hull","object_label":"Andrew Hull","object_source_name_forms":[],"value":"Andrew Hull: member, Audit","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:andrew-hull","name":"Andrew Hull"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-21T04:47:21.26074+00:00","sources":[{"id":"alpha:projection-evidence:ebf7b46941955283b019653e911fdb1bbfbc34681452ef5a323a9adbd2f08e80","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390025104914/ea0262858-def14a_inmed.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-21T04:47:21.26074+00:00","reviewed_at":"2026-10-21T04:47:21.26074+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_appointment:14","subject_id":"alpha:company:a2572fa4-f295-4e72-82fe-483a124bcdf0","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:nicole-lemerond","object_label":"Nicole Lemerond","object_source_name_forms":[],"value":"Nicole Lemerond: member, Audit","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:nicole-lemerond","name":"Nicole Lemerond"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-21T04:47:21.26074+00:00","sources":[{"id":"alpha:projection-evidence:ebf7b46941955283b019653e911fdb1bbfbc34681452ef5a323a9adbd2f08e80","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390025104914/ea0262858-def14a_inmed.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-21T04:47:21.26074+00:00","reviewed_at":"2026-10-21T04:47:21.26074+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_record:15","subject_id":"alpha:company:a2572fa4-f295-4e72-82fe-483a124bcdf0","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Compensation: Chair Nicole Lemerond; Members Nicole Lemerond (Chair); Andrew Hull","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Compensation","canonical_type":"compensation","chair":"Nicole Lemerond","members":[{"display_name":"Nicole Lemerond","person_slug":"nicole-lemerond","is_chair":true},{"display_name":"Andrew Hull","person_slug":"andrew-hull","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-21T04:47:21.26074+00:00","sources":[{"id":"alpha:projection-evidence:ebf7b46941955283b019653e911fdb1bbfbc34681452ef5a323a9adbd2f08e80","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390025104914/ea0262858-def14a_inmed.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-21T04:47:21.26074+00:00","reviewed_at":"2026-10-21T04:47:21.26074+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_appointment:16","subject_id":"alpha:company:a2572fa4-f295-4e72-82fe-483a124bcdf0","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:nicole-lemerond","object_label":"Nicole Lemerond","object_source_name_forms":[],"value":"Nicole Lemerond: chair, Compensation","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:nicole-lemerond","name":"Nicole Lemerond"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-21T04:47:21.26074+00:00","sources":[{"id":"alpha:projection-evidence:ebf7b46941955283b019653e911fdb1bbfbc34681452ef5a323a9adbd2f08e80","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390025104914/ea0262858-def14a_inmed.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-21T04:47:21.26074+00:00","reviewed_at":"2026-10-21T04:47:21.26074+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_appointment:17","subject_id":"alpha:company:a2572fa4-f295-4e72-82fe-483a124bcdf0","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:andrew-hull","object_label":"Andrew Hull","object_source_name_forms":[],"value":"Andrew Hull: member, Compensation","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:andrew-hull","name":"Andrew Hull"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-21T04:47:21.26074+00:00","sources":[{"id":"alpha:projection-evidence:ebf7b46941955283b019653e911fdb1bbfbc34681452ef5a323a9adbd2f08e80","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390025104914/ea0262858-def14a_inmed.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-21T04:47:21.26074+00:00","reviewed_at":"2026-10-21T04:47:21.26074+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_record:18","subject_id":"alpha:company:a2572fa4-f295-4e72-82fe-483a124bcdf0","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Nominating and Governance: Chair Andrew Hull; Members Andrew Hull (Chair); Nicole Lemerond","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Nominating and Governance","canonical_type":"nominating_governance","chair":"Andrew Hull","members":[{"display_name":"Andrew Hull","person_slug":"andrew-hull","is_chair":true},{"display_name":"Nicole Lemerond","person_slug":"nicole-lemerond","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-21T04:47:21.26074+00:00","sources":[{"id":"alpha:projection-evidence:ebf7b46941955283b019653e911fdb1bbfbc34681452ef5a323a9adbd2f08e80","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390025104914/ea0262858-def14a_inmed.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-21T04:47:21.26074+00:00","reviewed_at":"2026-10-21T04:47:21.26074+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_appointment:19","subject_id":"alpha:company:a2572fa4-f295-4e72-82fe-483a124bcdf0","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:andrew-hull","object_label":"Andrew Hull","object_source_name_forms":[],"value":"Andrew Hull: chair, Nominating and Governance","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:andrew-hull","name":"Andrew Hull"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-21T04:47:21.26074+00:00","sources":[{"id":"alpha:projection-evidence:ebf7b46941955283b019653e911fdb1bbfbc34681452ef5a323a9adbd2f08e80","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390025104914/ea0262858-def14a_inmed.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-21T04:47:21.26074+00:00","reviewed_at":"2026-10-21T04:47:21.26074+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_appointment:20","subject_id":"alpha:company:a2572fa4-f295-4e72-82fe-483a124bcdf0","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:nicole-lemerond","object_label":"Nicole Lemerond","object_source_name_forms":[],"value":"Nicole Lemerond: member, Nominating and Governance","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:nicole-lemerond","name":"Nicole Lemerond"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-21T04:47:21.26074+00:00","sources":[{"id":"alpha:projection-evidence:ebf7b46941955283b019653e911fdb1bbfbc34681452ef5a323a9adbd2f08e80","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390025104914/ea0262858-def14a_inmed.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-21T04:47:21.26074+00:00","reviewed_at":"2026-10-21T04:47:21.26074+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:d55657e2e1a85a098818eefcb09ca1c0203aefe37c594136198ef89ce00d144e","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"InMed Pharmaceuticals Inc. DEF 14A 2025-11-03","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390025104914/ea0262858-def14a_inmed.htm","source_date":"2025-11-03","retrieved_at":"2026-04-28T22:18:02.792+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:ebf7b46941955283b019653e911fdb1bbfbc34681452ef5a323a9adbd2f08e80","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390025104914/ea0262858-def14a_inmed.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.832,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.87,"cross_source_agreement":0.75,"temporal_completeness":0.538},"diagnostics":{"published_claims":20,"factual_claims":20,"claims_with_linked_evidence":20,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":13,"temporal_claims_with_valid_from":7,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-21T04:47:21.26074+00:00","observed_at":"2026-10-21T04:47:21.26074+00:00","reviewed_at":"2026-10-21T04:47:21.26074+00:00","verified_at":"2026-10-21T04:47:21.26074+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":20,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/inmed-pharmaceuticals-inc/committees","section":"committees","href":"https://registry.alpha.ac/api/public/companies/inmed-pharmaceuticals-inc?format=record&section=committees","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}